Plus Therapeutics Files for $34 Million Offering

On 9/10/19, Plus Therapeutics filed for a $34 million offering that will consist of Class A units, Class B units, common stock and warrants to purchase common stock. Plus is developing oncology drugs based on existing drugs delivered vis its nanoparticle technology. The company trades on NDADAQ under the symbol, "PSTV."